StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences total HBV / HDV Franchise (legacy sub-franchise breakout) ($M) ($M)

Form 10-Q / 10-K Disaggregated Revenue Note & Form 8-K Product Sales Summary

QuarterlyAnnual
Latest, Q4 2023
259
Period ended Dec 31, 2023
Change on a year earlier
+1.6%
255 in Q4 2022
History
16 quarters
Since Q1 2020
Sources
11
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal HBV / HDV Franchise (legacy sub-franchise breakout) ($M) ($M)Year on yearSource
Q4 2023Dec 31, 2023259+1.6%Form 10-K (filed 2024-02-23) ↗
Q3 2023Sep 30, 2023269+1.9%Form 10-Q (filed 2023-11-07) ↗
Q2 2023Jun 30, 2023259+10.7%Form 10-Q (filed 2023-08-04) ↗
Q1 2023Mar 31, 2023230-2.1%Form 10-Q (filed 2023-05-03) ↗
Q4 2022Dec 31, 2022255-3.8%Form 10-K (filed 2024-02-23) ↗
Q3 2022Sep 30, 2022264+6.9%Form 10-Q (filed 2023-11-07) ↗
Q2 2022Jun 30, 2022234-1.3%Form 10-Q (filed 2023-08-04) ↗
Q1 2022Mar 31, 2022235+6.8%Form 10-Q (filed 2023-05-03) ↗
Q4 2021Dec 31, 2021265+8.6%Form 10-K (filed 2024-02-23) ↗
Q3 2021Sep 30, 2021247+17.1%Form 10-Q (filed 2022-11-02) ↗
Q2 2021Jun 30, 2021237+8.2%Form 10-Q (filed 2022-08-08) ↗
Q1 2021Mar 31, 2021220+18.3%Form 10-Q (filed 2022-05-04) ↗
Q4 2020Dec 31, 2020244–Form 10-K (filed 2023-02-22) ↗
Q3 2020Sep 30, 2020211–Form 10-Q (filed 2021-11-03) ↗
Q2 2020Jun 30, 2020219–Form 10-Q (filed 2021-08-05) ↗
Q1 2020Mar 31, 2020186–Form 10-Q (filed 2021-05-06) ↗

Breakdown

What makes up total hbv / hdv franchise (legacy sub-franchise breakout) ($m)

Cite this data

StockData. (2026). Gilead Sciences Total HBV / HDV Franchise (legacy sub-franchise breakout) ($M) ($M), quarterly Q1 2020–Q4 2023 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/liver_hbv_hdv_total

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.